Abstract: The present disclosure provides a method for preparing lithium iron phosphate from ferric hydroxyphosphate, including: purifying ferrous sulfate to form a ferrous sulfate solution, adding hydrogen peroxide, phosphoric acid, an ammonium dihydrogen phosphate solution and ammonia water into the ferrous sulfate solution and then reacting to form a mixed slurry, holding the mixed slurry at a temperature for a period of time, and then washing with water and subjecting to press filtration to form ferric hydroxyphosphate precursors with different iron-phosphorus ratios; then flash drying, sintering at a high temperature, and pulverizing to obtain ferric hydroxyphosphate precursors with different iron-phosphorus ratios and different specific surface areas.

Abstract: The present disclosure provides a method for separating a neural crest derived cell from peripheral blood. In the present disclosure, a mononuclear cell is separated from the peripheral blood and then directly cultured, thereby maximizing use of a neural crest stem cell with a differentiation potential to avoid loss of the neural crest stem cell. In the method of the present disclosure, a sample to be separated is derived from the peripheral blood. The method shows less trauma and low cost. Most importantly, compared to extracting the neural crest derived cell from tissues, the neural crest derived cell extracted from the peripheral blood can be used clinically as a type of biomarker.

Abstract: A polypeptide complex comprises antibody variable regions of the heavy chain and light chain respectively fused to TCR constant regions. A bispecific antigen binding polypeptide complex contains a first antigen-binding moiety of the polypeptide complex and a second antigen-binding moiety. A method comprises producing the polypeptide complex of the bispecific antigen binding polypeptide complex. A method of treating disease or disorder comprises using the polypeptide complex or the bispecific antigen binding polypeptide complex. A polynucleotide encodes the polypeptide complex and/or the bispecific antigen binding polypeptide complex. A vector or a host cell contains the polynucleotide. A composition and a pharmaceutical composition comprise the polypeptide complex and/or the bispecific antigen binding polypeptide complex.

Abstract: The invention provides 3D-knitted spacer fabrics of high breathability and moisture management and methods of making the 3D-knitted spacer fabrics. The middle layer of the fabric is made of hydrophilic material, comprising two yarns, a blended thermo-fuse wicking yarn comprising hydrophilic fiber and thermo-fuse fiber, and a non-supportive hydrophilic functional wicking yarn. The top layer of the fabric comprises a hydrophilic yarn, and the third layer of the fabric comprises a hydrophobic yarn. The 3D-knitted spacer fabrics are useful in clothing and equipment for wear in high temperature environments.

Abstract: An implant delivery handle, an implant system, a delivery system and a method of use thereof are disclosed. Transmission systems in the implant delivery handle each include a lead screw, an inner tube coupling member, an outer gear and an inner gear. The outer gear rotatably engages the inner gear and is configured to drive rotation of the inner gear. The lead screw is coupled to a first inner tube (11) or a second inner tube (12) through the inner tube coupling member. The lead screw also engages the inner gear and rotates therewith to cause axial movement of the first inner tube (11) or the second inner tube (12). A transmission ratio of the outer gear to the inner gear is greater than 1.

Abstract: Methods, apparatus and systems for scheduling resources in a wireless communication are disclosed. In one embodiment, a method performed by a wireless communication node is disclosed. The method comprises: transmitting first resource information to a wireless communication device, wherein the first resource information comprises information related to a first resource associated with the wireless communication device; receiving a request from the wireless communication device on the first resource for a data transmission between the wireless communication node and the wireless communication device; and allocating, to the wireless communication device, a second resource in response to the request, wherein the second resource is configured to be utilized for the data transmission according to the request.

Abstract: A method for controlling data retransmission is provided. Data is transmitted to network device and a timer is started. The data is retransmitted after the timer expires if a HARQ-ACK feedback corresponding to the data is not received before the timer expires. Or the data is retransmitted if a HARQ-NACK feedback corresponding to the data is received from the network device before the timer expires.

Abstract: Provided is a compound of formula I or a pharmaceutically acceptable salt, enantiomer, diastereomer, tautomer, solvate, isotopic substituent, polymorph, prodrug, or metabolite thereof. Also provided is a method for preparing the compound of formula I. The compound of formula I has higher inhibitory activity against SHP2, and thus can be used to prevent or treat a disease related to SHP2.

Abstract: The present disclosure discloses a gradient single-crystal positive electrode material, which has a chemical formula of LiNixCoyA1-x-yO2@mLiaZbOc, wherein 0<x<1, 0<y<1, 0<x+y<1, 0<m<0.05, 0.3<a?10, 1?b<4, and 1?c<15, A is at least one of Mn, Zr, Sr, Ba, W, Ti, Al, Mg, Y, and Nb, and Z is at least one of B, Al, Co, W, Ti, Zr, and Si. The atomic ratio of the content of Co on the surface of the single-crystal positive electrode material particle to the content of Ni+Co+A on the surface is greater than 0.4 and less than 0.8, and the atomic ratio of Co at a depth 10% of the radius from the surface of the single crystal positive electrode material particle is not less than 0.3; and the single-crystal positive electrode material particle has a roundness of greater than 0.4, and is free from sharp corners.

Abstract: Embodiments of the present disclosure relate to methods and apparatuses for handover and reestablishment in a wireless communication system. According to some embodiments of the disclosure, a method may include: receiving, at a user equipment (UE), a radio resource control (RRC) reconfiguration message including a path switch indication and a list of candidate relays; selecting a target relay from the list of candidate relays; and establishing a PC5 RRC connection with the target relay. Furthermore, the UE may select another target relay for path switch if a path switch failure associated with the first selected target relay happens.

Abstract: The present invention discloses a recombinant collagen protein and its use in the cartilage repair matrix. The present invention discloses a recombinant collagen protein which contains the sequence shown in SEQ ID No. 1; the amino acid sequence of the stated recombinant collagen protein comprises N basic repetitive units; the basic repetitive unit contains n1 amino acid sequences with the following characteristic: G-Xaa1-Xaa2-G-E-Xaa3; the 3? end and the 5? end of the basic repetitive unit are connected to form the amino acid sequence with the above characteristic. The recombinant collagen protein claimed by the present invention has significant integrin binding activity, has the effect of promoting cell adhesion, proliferation, differentiation, and repairing cartilage tissue defects, etc, and it has promising prospects for application.

Abstract: A class of pyrimidoheterocyclic compounds, and specifically disclosed is a compound represented by formula (III) or a pharmaceutically acceptable salt thereof.

Abstract: 2-hydroxy-5-[2-(4-(trifluoromethylphenyl)ethylamino)]benzoic acid crystal forms and a preparation method therefor are proposed. Crystal form I is a monoclinic crystal system, which has a Pc space group and can be obtained by slow cooling, evaporating the solvent at a constant temperature, evaporating the solvent at an increased temperature, or adding an anti-solvent. Crystal form II is a triclinic crystal system, which has a P1 space group and can be obtained by rapid cooling or freeze-drying. According to the method, the process is simple, costs are low, and the yield exceeds 90%; and the crystal forms of the crystal forms I and II have high purity, the crystal shapes thereof are intact, and have excellent fluidity, facilitating preparation, particularly the preparation of a pharmaceutical preparation for preventing and/or treating degenerative diseases of the central nervous system. Furthermore, the two crystal forms have a better apparent solubility than that of raw materials.

Abstract: An embodiment of the present application discloses an HARQ process determination method, a network device and a terminal. The method comprises: the terminal determines HARQ process resource parameters; the terminal determines currently transmitted HARQ process resources on the basis of the HARQ process resource parameters; wherein, the current transmission is a non-dynamic transmission.

Abstract: Aspects of the disclosure relate to rate-matching a stream of bits encoded using polar codes. An exemplary method generally includes determining a mother code size (N) for transmitting an encoded stream of bits based, at least in part, on a minimum supported code rate for transmitting the encoded stream of bits (Rmin), a control information size of the encoded stream of bits (K), a number of coded bits for transmission (E), and a maximum mother code size (Nmax), encoding a stream of bits using a polar code of size (N, K) and storing the encoded stream of bits in a circular buffer, and performing rate-matching on the stored encoded stream of bits based, at least in part, on a comparison among the mother code size (N), the control information size of the encoded stream of bits (K), and the number of coded bits for transmission (E).

Abstract: A hierarchical health index evaluation method for an intelligent substation includes: obtaining a basic health index of a device based on static information and dynamic information of the device; obtaining a device correlation based on a communication connection relationship between the device and another device, and correcting the basic health index of the device based on the device correlation to obtain a health index of the device; obtaining a layer-based health index of a layer based on a device health index and a device importance weight of the layer; obtaining a whole-station health index of an intelligent substation based on a layer-based health index of each layer and a sum of device importance weights of each layer; and regulating the intelligent substation based on a health index of each device in the intelligent substation, the layer-based health index of each layer, and the whole-station health index.

Abstract: Provided is a method of ion beam processing based on optical microscopy imaging, including: marking a surface of a sample using the ion beam, so as obtain a registration reference pattern; performing a three-dimensional optical imaging on the sample to obtain a first three-dimensional light microscopy image; projecting the first three-dimensional light microscopy image to a cutting angle of the ion beam, and determining a first position of a to-be-researched target in the first three-dimensional light microscopy image based on the registration reference pattern; performing an ion beam imaging on the sample to obtain an image excited by the ion beam, and determining, according to the first position, a second position of the to-be-researched target in the image excited by the ion beam; and thinning the sample according to the second position to obtain a first slice containing the to-be-researched target.

Abstract: Example aspects include an apparatus and method of wireless communication by a reduced capability user equipment (RedCap UE) in a network, comprising sending, to a non-RedCap UE, an indication indicating the RedCap UE as a RedCap UE device. The aspects further include performing sidelink communications with the non-RedCap UE in accordance with capabilities of the RedCap UE.

Abstract: Provided is a utidelone liposome composition. The liposome composition mainly contains utidelone, a phospholipid, and optional cholesterol. The liposome composition does not contain an excipient that is prone to causing an allergic reaction of a human body, has a high drug loading capacity and stability, and has a good industrialization potential. Further provided are a method for preparing the utidelone liposome composition and the use thereof.

Abstract: An electronic vaporization device includes a battery, a storage unit and a heating element a thermistor, provided close to the heating element, heat of the heating element being able to be transferred to the thermistor, resulting in a change in a resistance value of the thermistor, and the thermistor being electrically connected with the heating element and the battery to form an electrical circuit and a control module, configured to acquire a starting signal to conduct electrical connection of the electrical circuit, the electrical circuit being configured in such a way that during conduction, the change in the resistance value of the thermistor reduces a current flowing through the heating element. The resistance value of the thermistor is changed by sensing the temperature of the heating element, when inhaling, the current flowing through the heating element can be reduced along with the change in the resistance value of the thermistor.